EUVIMEDEUVIMED entdecken
Crossref

Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma

Md. Mahbubol Alam, Rifah Tamanna Begum, Sumon Ahmed Suvo, Fahamida Binta Anower, Sahariare Nazim, Md. Fardin Islam, Md. Imam Mahdi Ratul

Asian Journal of Applied Science and Technology · 2026 · 10 (02) · 126-140

DOI: 10.38177/ajast.2026.10210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Applied Science and Technology, 2026. Verfasst von Md. Mahbubol Alam und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) is still one of the main causes of death from cancers globally; hence, there is a need for developing new biomarkers and targets for diagnosis and treatment. This work involves analyzing the involvement of Pyrroline-5-carboxylate reductase 1 (PYCR1) through multidimensional bioinformatic approaches on LUAD data obtained from „The Cancer Genome Atlas (TCGA)‟ portal-UALCAN. Our findings indicate that PYCR1 is highly expressed in LUAD tissue samples than normal lungs (p < 1E-12) with a consistent increase in its expression irrespective of age group, gender, or smokers/non-smokers. Elevated PYCR1 was positively associated with more advanced clinical stages of tumors and lymph node metastasis. Moreover, we found that the expression of PYCR1 is highly up-regulated in response to TP53 mutations with hypomethylation of its promoter, thus implying a novel mechanism of transcriptional activation of PYCR1. Notably, the analysis showed that high expression of PYCR1 is an independent marker predicting poor survival. This makes PYCR1 a reliable biomarker with both diagnostic and prognostic value and demonstrates the significance of a metabolic-genetic axis in cancer development. The study concludes that PYCR1 proline pathway modulation can be used as a novel therapy to treat lung adenocarcinoma.

Zitieren

APA

Alam, M. M., Begum, R. T., Suvo, S. A., Anower, F. B., Nazim, S., Islam, M. F., & Ratul, M. I. M. (2026). Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma. Asian Journal of Applied Science and Technology, 10(02), 126-140. https://doi.org/10.38177/ajast.2026.10210

Vancouver

Alam MM, Begum RT, Suvo SA, Anower FB, Nazim S, Islam MF, et al. Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma. Asian Journal of Applied Science and Technology. 2026;10(02):126-140. doi:10.38177/ajast.2026.10210

BibTeX
@article{Alam2026,
  author = {Alam, Md. Mahbubol and Begum, Rifah Tamanna and Suvo, Sumon Ahmed and Anower, Fahamida Binta and Nazim, Sahariare and Islam, Md. Fardin and Ratul, Md. Imam Mahdi},
  title = {Integrated Bioinformatics Analysis Reveals the Clinical and Epigenetic Significance of PYCR1 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Lung Adenocarcinoma},
  journal = {Asian Journal of Applied Science and Technology},
  year = {2026},
  volume = {10},
  number = {02},
  pages = {126--140},
  doi = {10.38177/ajast.2026.10210}
}
Kostenlos starten →